Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial.
- DOI
- 10.1136/jitc-2021-002568
- Published
- 2021 Jun
- Container
- Journal for immunotherapy of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2021-002568,
title = {Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial.},
author = {Ferris RL and Spanos WC and Leidner R and Gonçalves A and Martens UM and Kyi C and Sharfman W and Chung CH and Devriese LA and Gauthier H and Chiosea SI and Vujanovic L and Taube JM and Stein JE and Li J and Li B and Chen T and Barrows A and Topalian SL},
year = {2021},
journal = {Journal for immunotherapy of cancer},
doi = {10.1136/jitc-2021-002568},
url = {https://doi.org/10.1136/jitc-2021-002568}
}RIS
TY - JOUR TI - Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial. AU - Ferris RL AU - Spanos WC AU - Leidner R AU - Gonçalves A AU - Martens UM AU - Kyi C AU - Sharfman W AU - Chung CH AU - Devriese LA AU - Gauthier H AU - Chiosea SI AU - Vujanovic L AU - Taube JM AU - Stein JE AU - Li J AU - Li B AU - Chen T AU - Barrows A AU - Topalian SL PY - 2021 JO - Journal for immunotherapy of cancer DO - 10.1136/jitc-2021-002568 UR - https://doi.org/10.1136/jitc-2021-002568 ER -
APA
RL, F., WC, S., R, L., A, G., UM, M., C, K., W, S., CH, C., LA, D., H, G., SI, C., L, V., JM, T., JE, S., J, L., B, L., T, C., A, B., & SL, T. (2021). Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2021-002568
Source records
- pubmed · retrieved 2026-09-26T17:37:11.071Z